-transparent.png){kind=logo}
The anxiogenic effects of yohimbine, a specific alpha-2-receptor antagonist were examined by administering 20 mg yohimbine orally to 8 panic patients on placebo treatment, 7 panic patients on alprazolam treatment and 12 controls using a double-blind randomized design, instructions that minimized the expectancy of experiencing a panic attack and two additional structured situations. Yohimbine induced more pronounced increases in anxiety and panicky ratings, norepinephrine secretion, maximum heart rate and high heart rate variability and decreases in skin temperature in panic patients compared with controls. However, possibly owing to an instructional set and experimental design that distracted patients from unpleasant bodily sensations no panic attacks were observed.
M Albus, and
T P Zahn, and
A Breier
July 1974,
Archives internationales de pharmacodynamie et de therapie,
M Albus, and
T P Zahn, and
A Breier
January 1993,
Life sciences,
M Albus, and
T P Zahn, and
A Breier
May 1978,
European journal of pharmacology,
M Albus, and
T P Zahn, and
A Breier
October 1971,
Psychopharmacology bulletin,
M Albus, and
T P Zahn, and
A Breier
August 1987,
The American journal of psychiatry,
M Albus, and
T P Zahn, and
A Breier
November 2005,
The Journal of comparative neurology,
M Albus, and
T P Zahn, and
A Breier
July 1984,
Psychological bulletin,
M Albus, and
T P Zahn, and
A Breier
November 1985,
Brain research,
M Albus, and
T P Zahn, and
A Breier
May 1961,
Psychological bulletin,
M Albus, and
T P Zahn, and
A Breier
January 1986,
Psychopharmacology,
